At baseline, a PD‐L1 expression of TC ≥ 1% was recorded in 18 (27.7%) and 33 (55.9%) patients with BTC and ESCC, respectively (Table 1). This evidence concerns the gene CD274 and esophageal squamous cell carcinoma.